Representative image (Reuters)
The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm).
- Reuters Beijing
- Last Updated:February 25, 2021, 20:15 IST
- FOLLOW US ON:
China’s National Medical Products Administration said on Thursday that it had approved two more COVID-19 vaccines for public use, increasing the number of domestic vaccines approved in China to four.
The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm).
They join a vaccine from Sinovac Biotech approved earlier this month, and another from Sinopharm’s Beijing unit approved last year.
So far, China has not approved COVID-19 vaccines developed by Western drug makers.
Sinopharm’s Wuhan unit said on Wednesday its vaccine had an efficacy rate of 72.51% against the COVID-19 disease caused by the virus,…
